Researchers at the Salk Institute have built a light-based tool that can rapidly and reversibly switch autophagy, the cell's self-recycling process, on and off. The tool, called ASAP (Autophagic SNARE for Abrupt Photomanipulation), is described in a study led by Christina Towers, PhD, and published in Nature Cell Biology on November 12, 2026.
Autophagy is often described as the cell's quality control system. When a protein or cellular structure becomes old or malfunctioning, autophagy clears it away so its components can be reused. Dysfunctional autophagy has been linked to many diseases, but Towers has said that studying how it selects its targets has been very hard for decades, largely because researchers lacked good tools. ASAP is designed to address that gap. It is an optogenetic tool, a technique in which cells are engineered to respond to light. The researchers built a protein that, after a brief pulse of light, relocates to block autophagy in the target cell.
Using ASAP in human cells grown in petri dishes, the team blocked autophagy and screened the cells' protein content at intervals from five minutes to 60 minutes. They confirmed many proteins already known to be autophagy targets, which first author Payel Mondal, PhD, said showed the tool was working. They also identified proteins that had not previously been linked to autophagy. One was the nuclear pore complex, the gatekeeper that controls traffic between the nucleus and the rest of the cell. Working with a team at Sanford Burnham Prebys, the researchers found that autophagy targets only partially built nuclear pore complexes and spares healthy ones.
The study also found that blocking autophagy led to rapid accumulation of protein condensates, which regulate protein translation, and that this buildup followed the pileup of nuclear pore proteins. According to the researchers, this is the first work to link protein translation, the making of proteins, with autophagy, the breakdown of proteins, in such a specific way. Towers' lab plans to use ASAP to study cancer cells, and other researchers have expressed interest in applying it to neurons. The authors suggest future studies could reveal disease-relevant autophagy targets in neurodegeneration, cancer, aging, and infection.